Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/qualitative-and-quantitative-assessment-of-endpoints-in-clinical-v6llNXNO5r
References (7)
-
E. Saad, A. Katz, P. Hoff, M. Buyse (2010)
Progression-free survival as surrogate and as true end point: insights from the breast and colorectal cancer literature.Annals of oncology : official journal of the European Society for Medical Oncology, 21 1
-
J. Cuzick, I. Šestak, M. Baum, A. Buzdar, A. Howell, M. Dowsett, J. Forbes (2010)
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial.The Lancet. Oncology, 11 12
-
E. Saad, Artur Katz (2009)
Progression-free survival and time to progression as primary end points in advanced breast cancer: often used, sometimes loosely defined.Annals of oncology : official journal of the European Society for Medical Oncology, 20 3
-
E. Eisenhauer, P. Therasse, J. Bogaerts, L. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, Lawrence Rubinstein, L. Shankar, L. Dodd, Robert Kaplan, D. Lacombe, J. Verweij (2009)
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).European journal of cancer, 45 2
-
D. Sargent, S. Patiyil, G. Yothers, D. Haller, R. Gray, J. Benedetti, M. Buyse, R. Labianca, J. Seitz, C. O'Callaghan, G. Francini, A. Grothey, M. O’connell, P. Catalano, D. Kerr, E. Green, H. Wieand, R. Goldberg, A. Gramont (2007)
End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 29
-
K. Broglio, D. Berry (2009)
Detecting an overall survival benefit that is derived from progression-free survival.Journal of the National Cancer Institute, 101 23
-
B. Cheson, B. Pfistner, M. Juweid, R. Gascoyne, L. Specht, S. Horning, B. Coiffier, R. Fisher, A. Hagenbeek, E. Zucca, S. Rosen, S. Stroobants, T. Lister, R. Hoppe, M. Dreyling, K. Tobinai, J. Vose, J. Connors, M. Federico, V. Diehl (2007)
Revised response criteria for malignant lymphoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 5
- Publisher
- Springer Journals
- Copyright
- Copyright © 2010 by Springer
- Subject
- Medicine & Public Health; Medicine/Public Health, general ; Oncology
- ISSN
- 1865-5041
- eISSN
- 1865-5076
- DOI
- 10.1007/s12254-010-0178-7
- Publisher site
- See Article on Publisher Site
Abstract
This review discusses the complexities of different endpoints in clinical trials. A definition of these endpoints and their value for specific situations will be evaluated.
Journal
memo - Magazine of European Medical Oncology – Springer Journals
Published: Apr 14, 2010